At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.
I am taking care of a patient with a history of severe recurrent depression. Although she did relatively well during pregnancy on duloxetine 120 mg, she experienced recurrent, severe depressive symptoms after giving birth. [...]
Using a wearable device to track daily symptoms of postpartum depression was viewed as acceptable and clinically useful by participants and clinicians.
Many women experience depression during pregnancy. What is the best way to identify these women?
We are now recruiting for a study using a novel app using behavioral activation to treat depression during pregnancy.
Electroconvulsive therapy (ECT) is a safe and effective treatment for many psychiatric illnesses occurring during pregnancy.
This article focuses on how GABA-ergic neurotransmitter systems may modulate the interaction between reproductive steroid and sex steroid systems, and sheds light on the role allopregnanolone may play in medicating vulnerability to depression.
Infants exposed to maternal depression during pregnancy had significantly larger subcortical grey matter volumes and smaller midbrain volumes.
Women may experience depression and post-traumatic symptoms, especially those who were separated from their newborns after delivery and those with severe COVID-19 illness during pregnancy or after delivery.
The reality is that most of the antidepressants taken by women today are relatively safe and carry a very low risk to the developing fetus.
